Seeking Alpha

The police

The police
Send Message
View as an RSS Feed
View The police's Comments BY TICKER:
Latest  |  Highest rated
  • Things To Consider About AstraZeneca's Partnership With Inovio [View article]
    oops MIT!
    Aug 13, 2015. 10:37 PM | Likes Like |Link to Comment
  • Inovio Pharmaceuticals: AstraZeneca Deal Could Be A Game Changer [View article]
    dMABs are better than CAR-T. And they are around $10,000 a treatment versue $200,000. Do some research. They are the next blockbuster.
    Aug 13, 2015. 09:16 PM | 4 Likes Like |Link to Comment
  • Things To Consider About AstraZeneca's Partnership With Inovio [View article]
    Adam F has his college degree in politics and government. Did you know that? I will take Dr. Kim and his UPENN and Harvard education over an alcoholic socialist. You will be eating crow in the next year.

    "Dr. Kim earned a Bachelor of Science degree in Chemical Engineering and Economics from the Massachusetts Institute of Technology (MIT), where he was a U.S. Senate Honors Scholar. He holds a PhD in Biochemical Engineering from the University of Pennsylvania and a Master of Business Administration degree in Finance from the Wharton School. Dr. Kim has published more than 100 peer-reviewed scientific papers, holds numerous patents and sits on several editorial boards and review panels."
    Aug 12, 2015. 09:57 PM | 7 Likes Like |Link to Comment
  • Inovio Pharmaceuticals: Small Vaccine Maker Worthy Of Consideration [View article]
    VGX-3100 is going Phase III within a year.
    May 30, 2015. 06:03 PM | 7 Likes Like |Link to Comment
  • Inovio Pharmaceuticals: Small Vaccine Maker Worthy Of Consideration [View article]
    INO will be worth Billions by 2017. Many are about to miss the INO train. As Dr. Kim says, get ready for some shock and awe.

    Just look at brilliant Scientific Advisory Board
    David B. Weiner, Ph.D., Chairman
    Professor, University of Pennsylvania
    Synthetic vaccine pioneer
    Anthony Ford-Hutchinson, Ph.D.
    Former SVP, Merck Vaccines R&D
    Philip D. Greenberg, M.D.
    Head, Program of Immunology, Fred
    Hutchinson Cancer Research Center
    Stanley A. Plotkin, M.D.
    Emeritus Professor, Wistar & UPenn
    Principal Vaxconsult
    May 30, 2015. 05:16 PM | 9 Likes Like |Link to Comment
  • Dendreon Provides A Major Warning To Shareholders [View article]
    Why would they wipe out shareholders. That means all executives and insiders would lose their shares as well. I doubt institutions and the BOD would let this happen. Get real. Buy more.
    Aug 14, 2014. 11:31 PM | 2 Likes Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    LEEP procedure is not available in 3rd world countries. In USA we are privalaged and have FDA.

    Across the globe they will have Inovio.
    Jul 26, 2014. 10:34 AM | 1 Like Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    THey dont have leep Around the globe , maybe in America. TIme to think globally. HPV is global... but people will never understand.
    Jul 26, 2014. 10:34 AM | 1 Like Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    What was the overall clearance. It has to be higher than 40%. 40% in is regression and clearance. What about just clearance. That is Dr. Kims Ace in the hole. Maybe 70% clearance... Without his immures activators.
    Jul 25, 2014. 03:22 PM | 1 Like Like |Link to Comment
  • 3 Convincing Reasons To Buy Dendreon [View article]
    3 weeks out and no CEO successor? That s because there will be a buyout. No new CEO needed.
    Jul 24, 2014. 02:58 PM | 2 Likes Like |Link to Comment
  • Dendreon May Still Be In Play [View article]
    Then it shows that Allergen wants to make a bio similar? It would be cheaper to buy them out than make a bio similar , R&D proprietary methods etc.
    Jun 25, 2014. 01:43 AM | Likes Like |Link to Comment
  • Dendreon May Still Be In Play [View article]
    Why does Allergan own internet domain names for Dendreon products?
    Jun 24, 2014. 09:12 PM | 2 Likes Like |Link to Comment
  • Dendreon: An Update On The Debt Situation [View article]
    Also, Allergan owns domain names for Lapuleucel-T and Sipuleucel-T. Why do think this is true?
    Jun 18, 2014. 03:46 PM | Likes Like |Link to Comment
  • Dendreon: An Update On The Debt Situation [View article]
    Allergan owns domain names for Lapuleucel-T and Sipuleucel-T. Why do this this is true?
    Jun 18, 2014. 01:56 PM | 1 Like Like |Link to Comment
  • Inovio Price Volatility: Market-Naive Moves By Management And Confusion Over Scientific Issues [View article]
    Where else has this been covered. Links / sources please.
    Jun 18, 2014. 01:35 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
31 Comments
67 Likes